ALKBH1 and hypertensive disorder: Their findings suggested 6mA as sensitive marker for diagnosis of hypertension and ALKBH1 as novel therapeutic target to prevent hypertension through epigenetic reprogramming because ALKBH1 mediates cross talk between 6mA DNA level and H1F1α activity.